AIMS
The aim of the present study was to investigate possible influences of a panel of markers in the dysbindin gene DTNBP1 (rs3213207, rs1011313, rs2005976, rs760761 and rs2619522) on the clinical outcome and side effects associated to the treatment with aripiprazole in schizophrenic patients.
METHODS
Efficacy was assessed at baseline and weeks 1, 2, 4, 6 and 8 using the Clinical Global Impr...